We are Sorry, This Page doesn't Exist
The Zacks Analyst Blog Highlights: CRH, Grafton Group, Johnson Controls International and Ryanair
Zacks.....»»
The Zacks Analyst Blog Highlights: AbbVie, Abbott Labs, Allergan, Johnson & Johnson and Merck
Zacks.....»»
The Zacks Analyst Blog Highlights: Johnson & Johnson, Boeing, Pfizer, Qualcomm and Mitsubishi UFJ Financial
Zacks.....»»
The Zacks Analyst Blog Highlights: Johnson & Johnson, Boeing, Broadcom, Anthem and Allstate
Zacks.....»»
Bayer & JNJ Settle Numerous Xarelto Lawsuits for $775 Million
Bayer (BAYRY) and partner Johnson & Johnson settle about 25,000 claims over blood thinn.....»»
Johnson & Johnson and Bayer Settle Xarelto Lawsuits for $775 Million
The drug companies agreed to settle more than 25,000 lawsuits in the U.S. and admit no liability. Two pharmaceutical giants agreed on Monday to settle more than 25,000 lawsuits in the United States in which plaintiffs a.....»»
Bayer, J&J settle U.S. Xarelto litigation for $775 million
Bayer AG and Johnson & Johnson have agreed to settle more than 25,000 U.S. lawsuits over their blockbuster blood thinner Xarelto for a total of $775 million, court documents on Monday showed......»»
Bayer, Johnson & Johnson"s Xarelto fails trial to widen use, Reuters says
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Bayer, J&J"s blood-thinning drug Xarelto fails "Mariner" trial
Bayer AG and Johnson & Johnson’s blood-thinning drug Xarelto didn’t prevent clotting in high-risk patients after they were released from the hospital, a setback for one of the manufacturers’ best-selling drugs......»»
The Zacks Analyst Blog Highlights: Novartis, AstraZeneca, Merck, Pfizer and Johnson & Johnson
Zacks.....»»
The Zacks Analyst Blog Highlights: Johnson & Johnson, Netflix, Microsoft, Amazon and Alphabet
Zacks.....»»
The Zacks Analyst Blog Highlights: Alphabet, Walgreens Boots, Johnson & Johnson and Amazon
Zacks.....»»
The Zacks Analyst Blog Highlights: Amazon, Johnson & Johnson, Home Depot, Medtronic and Paychex
Zacks.....»»
Johnson & Johnson Set To Resume COVID-19 Vaccine Rollout In Europe — With A Warning On The Label
Johnson & Johnson (NYSE: JNJ) said Tuesday that the European rollout of its COVID-19 vaccine is set to continue after it got the go-ahead from the regulator on the continent. read more.....»»
Johnson & Johnson profit and sales surge, beating analyst forecasts
Big jumps in sales of prescription drugs and medical devices helped Jo.....»»
The Daily Biotech Pulse: Q1 Beat From Johnson & Johnson, KalVista Study Placed On Hold, European Label Expansion For GW Pharma"s Epidiolex
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 15) read more.....»»